Daniel Helbling
0000-0002-2717-1817
1 paper found
Refreshing results…
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Missing publications? Search for publications with a matching author name.